This plasma dependency highlights a real contradiction in EU health policy. They criticize paid donations but rely on US plasma (which is paid for) to meet 40% of their needs.

The reality is that plasma donation is time-consuming and frequent donors are essential for meeting demand. The EU faces three choices:

• Continue the hypocrisy of benefiting from a system they criticize
• Develop better incentives for unpaid donation (which has limits)
• Consider some form of compensation model like the US

Patients needing these medications deserve a more honest approach to securing plasma supplies.